CI vs ELV
CI and ELV side by side — valuation & fundamentals (public data).
Key statistics
| Metric | CIThe Cigna Group | ELVELEVANCE HEALTH, INC. |
|---|---|---|
| Market cap | $73.69B | $85.62B |
| P/E (TTM) | 11.5 | 17.5 |
| P/B | 1.73 | 1.91 |
| P/S | 0.3x | 0.4x |
| Dividend yield | 2.19% | 1.79% |
| Revenue | $282.38B(TTM) | $201.11B(TTM) |
| Revenue growth (YoY) | 11.2% | 12.5% |
| Net income | $6.42B(TTM) | $4.96B(TTM) |
| Earnings growth (YoY) | 73.5% | -5.3% |
| EPS, diluted | $24.18(TTM) | $22.61(TTM) |
| EBIT margin | 3.3% | 3.6% |
| ROE | 14.0% | 12.6% |
| ROIC | 9.5% | 9.3% |
| 1y total return | -4.7% | +29.5% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: CI vs ELV
| Metric | CI | ELV |
|---|---|---|
| End value | $22.2K | $31.5K |
| Total return | +121.6% | +214.6% |
| CAGR | +8.0% | +11.7% |
| Volatility | 30.6% | 31.0% |
| Sharpe | 0.28 | 0.39 |
| Sortino | 0.39 | 0.55 |
| Max drawdown | -42.5% | -50.4% |
Based on 2600 common trading days, 2016-04-27 → 2026-08-28 · risk-free 3.9% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)